Amryt Pharma plc American Depositary Shares
AMYT
AMYT was delisted on the 11th of April, 2023.
57 hedge funds and large institutions have $318M invested in Amryt Pharma plc American Depositary Shares in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 10 reducing their positions, and 9 closing their positions.
114% more call options, than puts
Call options by funds: $30K | Put options by funds: $14K
40% more funds holding in top 10
Funds holding in top 10: 5 → 7 (+2)
20% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 10
1% more capital invested
Capital invested by funds: $315M → $318M (+$2.83M)
8% less funds holding
Funds holding: 62 → 57 (-5)
56% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$744K |
| 2 |
ACM
Aquilo Capital Management
San Francisco,
California
|
+$705K |
| 3 |
Wells Fargo
San Francisco,
California
|
+$446K |
| 4 |
Handelsbanken Fonder
Stockholm,
Sweden
|
+$290K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$219K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$13.8M |
| 2 |
AC
Armistice Capital
New York
|
-$2.07M |
| 3 |
Millennium Management
New York
|
-$852K |
| 4 |
NAM
Nexpoint Asset Management
Dallas,
Texas
|
-$277K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$168K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BC
51
Burleson & Co
Petaluma,
California
| $161 | – | – | – |
|
52
National Bank of Canada
Montreal,
Quebec, Canada
| $73 | – | – | – |
|
|
LWANC
53
Laurel Wealth Advisors (North Carolina)
Charlotte,
North Carolina
| $30 | +$28 | +4 | New |
|
|
FDCDDQ
54
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $29 | – | – | – |
|
|
AIG
55
American International Group
New York
| $15 | – | – | – |
|
|
NA
56
NewEdge Advisors
New Orleans,
Louisiana
| $1 | +$1.21K | +171 | New |
|
|
UOC
57
UBS O'Connor
Chicago,
Illinois
| – | -$13.8M | -2,000,000 | Closed |
|
|
NAM
58
Nexpoint Asset Management
Dallas,
Texas
| – | -$277K | -40,000 | Closed |
|
59
D.E. Shaw & Co
New York
| – | -$155K | -22,428 | Closed |
|
|
GCP
60
GSA Capital Partners
London,
United Kingdom
| – | -$98K | -14,094 | Closed |
|
61
Goldman Sachs
New York
| – | -$73K | -10,609 | Closed |
|
|
AIM
62
Axiom Investment Management
New York
| – | -$2K | -277 | Closed |
|
|
BWL
63
Bogart Wealth LLC
Mclean,
Virginia
| – | -$1K | -99 | Closed |
|
AMYT Hedge Fund Activity: Q4 2022 in Review
57 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Amryt Pharma plc American Depositary Shares (AMYT) for Q4 2022, worth a combined $318M — up 0.9% from $315M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of AMYT and 4 opened new positions — a net loss of 5 holders — while 10 trimmed existing stakes and 12 added.
The largest buyer was Stonepine Capital Management, adding an estimated $744K. The largest seller was UBS O'Connor, exiting entirely with an estimated $13.8M sold.
- 57 institutional investors held Amryt Pharma plc American Depositary Shares (AMYT) as of Q4 2022, down from 62 in Q3 2022.
- Funds reported $318M of Amryt Pharma plc American Depositary Shares stock for Q4 2022, up 0.9% quarter-over-quarter.
- 4 funds opened new Amryt Pharma plc American Depositary Shares positions in Q4 2022 and 9 closed out, a net change of -5 holders.
- The largest Amryt Pharma plc American Depositary Shares buyer in Q4 2022 was Stonepine Capital Management, an estimated $744K added.
- The largest Amryt Pharma plc American Depositary Shares seller in Q4 2022 was UBS O'Connor, an estimated $13.8M sold.
Based on aggregated 13F filings for Q4 2022.